
    
      This is an observational and descriptive study that will provide preliminary comparative
      information about the safety and immunogenicity of FluzoneÂ® vaccine among children aged 6 to
      12 weeks (the investigational group, also referred to as the 2-month-old group) versus
      children aged 24 to 36 weeks (the control group, also referred to as the 6-month-old group).
      The study is not designed to achieve any preset statistical power, and no hypotheses will be
      tested.
    
  